Remdesivir

Friday, Aug 19, 2022 | Last Update : 04:54 AM IST

Molnupiravir, an oral pill, was authorised for use in December, 2021. (Photo: AP/File)

New antiviral drug combo highly effective against COVID-19: Study

Combining remdesivir or molnupiravir with experimental drug brequinar blocks reproduction of SARS-CoV-2 virus, the study said

09 Feb 2022 12:25 PM

Scientists say the case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of using a combination of therapies in immunocompromised patients. (AP File Image)

Mutation linked to remdesivir resistance found in Covid patient

Genetic analysis of the virus showed that it acquired a mutation during treatment that appeared to reduce the effectiveness of the drug

11 Nov 2021 1:52 PM

In order to substantially augment the production of Remdesivir, the Drugs Controller General of India granted expeditious approval to 40 new manufacturing sites of licensed manufacturers of the drug. (PTI Photo)

India's Remdesivir prod'n capacity rises to 122.49 lakh vials per month in June: Govt

The MoHFW has also supplied around 29 lakh Remdesivir vials free of cost to states and UTs

03 Aug 2021 4:07 PM

The idea behind the future drug would be that it works early in the infection. (Representational image: AP)

Scientists find new drug target to treat coronavirus, fight future pandemic

The latest study provides critical information that could aid drug development against future coronaviruses as well as SARS-CoV-2

08 Jul 2021 1:19 PM

Union Finance Minister Nirmala Sitharaman speaks during a press conference after chairing the 44th GST Council meeting via video conferencing, in New Delhi, Saturday, June 12, 2021. (Photo:PTI)

GST slashed on COVID-19, black fungus medicines; 5% tax retained on vaccines

The reduced tax rates were based on a recommendation of a group of ministers, headed by Meghalaya Deputy Chief Minister Conrad Sangma

13 Jun 2021 7:38 AM

The guidelines have mentioned the use of Remedesivir. (Photo: PTI/File)

Health Ministry issues guidelines for rational use of medicines, tests for COVID-19 patients

The guidelines have stressed the use of wearing masks, physical distancing and hand hygiene

07 Jun 2021 3:06 PM

A doctor examines a man for the symptoms of mucormycosis at a government hospital in Mumbai, May 25, 2021. (AP /Rafiq Maqbool)

Why is medical care making Covid-hit sicker, poorer in India?

Indians with Covid-19 are advised to take a large assortment of minerals and vitamins that again have not been shown to be effective

04 Jun 2021 1:40 AM

Any overzealous, though well-meaning judicial intervention may lead to unforeseen and unintended consequences in absence of any expert advice, the Centre told the top court. — AFP

Differential vaccine pricing is right, Centre tells Supreme Court

Government defends move, says it is to incentivise vaccine makers

11 May 2021 7:54 AM

The Mumbai police detained and questioned the director, whose identity has not been revealed, of Daman-based Bruck Pharmaceuticals, after it got information that thousands of vials of Remdesivir used in Covid-19’s teatment were to be flown out of the country. (Twitter)

Top Remdesivir supplier grilled in Mumbai as MVA & BJP tussle

Furious BJP leaders have accused the Maharashtra state government of harassing the Remdesivir suppliers in the state

19 Apr 2021 12:39 AM

Chief of Army Staff General MM Naravane and Harsh V Shringla, Foreign Secretary along with Saurabh Kumar called on State Counsellor H.E. Daw Aung San Suu Kyi. (Via Indian Embassy in Myanmar)

India gives 3,000 vials of Remdesivir to 'friendly' Myanmar to help fight COVID-19

General Naravane and Shringla's two-day visit to Myanmar assumes significance as it comes in the midst of the India-China standoff

05 Oct 2020 3:23 PM

A surplus of remdesivir marks a turnaround from earlier in the pandemic, when supplies of the drug had fallen short of demand in some regions.

US hospitals turn down remdesivir, limit use to severely ill since July

The slowdown suggests that a shortage of the drug is over and threatens Gilead’s efforts to expand use of remdesivir

12 Sep 2020 1:10 PM

Dr Reddy's launches Remdesivir for COVID-19 treatment in India. (AP Photo)

Dr. Reddy’s releases COVID drug Remdesivir under brand name Redyx

"Dr Reddy's Redyx is available in strength of 100 mg vial," it said

09 Sep 2020 12:21 PM

Zydus Cadila launched the cheapest generic version of Gilead Sciences’ antiviral drug remdesivir in India. (Photo- Twitter)

India's cheapest remdesivir version launched by Zydus Cadila at Rs 2,800 per vial

The drug will be sold under the brand name Remdac to government and private hospitals treating COVID-19 patients

13 Aug 2020 11:01 AM

Maharashtra’s Food and Drug Administration (FDA) plans to buy remdesivir from a Gujarat-based company. (ANI Photo)

Maharashtra FDA to buy remdesivir from Gujarat firm

State FDA minister Rajendra Shingne said the government plans to publish the price and availability of the drugs online for transparency

26 Jul 2020 3:55 PM

Jubilant Generics gets nod to manufacture, market anti-viral drug Remdesivir. (Representational Image)

Jubilant Generics gets DCGI nod to manufacture COVID-19 drug Remdesivir

On June 21, Hetero and Cipla and on July 2 Mylan were given permission to manufacture and market the drug on the same conditions

21 Jul 2020 10:01 AM

Mumbai crime branch busted a racket selling Covid-19 immunity booster injections Remdesivir at exorbitant cost and arrested seven persons. (AFP Photo)

Seven held for selling Remdesivir injections at higher cost

The officials said that each vial of the injection was being sold at 30,000 instead of 4,500

20 Jul 2020 12:50 PM

Gilead Sciences Inc said on Wednesday it has started an early-stage study of its antiviral COVID-19 treatment remdesivir that can be inhaled. (AFP Photo)

Gilead starts testing inhaled version of remdesivir for COVID-19

Gilead also plans to start additional clinical trials to evaluate remdesivir when used in combination with anti-inflammatory medicines

09 Jul 2020 9:10 AM

Mylan gets DCGI nod for remdesivir in India, to launch at Rs 4,800 per vial. (Photo- Twitter)

Mylan Pharma to launch remdesivir in India at Rs 4,800 per 100 mg vial

The drug will be launched under the brand name Desrem in India and will be available to patients later this month

07 Jul 2020 1:48 PM

Vials of the drug 'remdesivir' during a press conference concerning the start of a study with the Ebola drug to treat severely ill patients afflicted with coronavirus COVID-19, at The University Hospital Eppendorf (UKE) in Hamburg, northern Germany, amidst the global pandemic. (AFP)

Remdesivir gets conditional EU clearance to be used in severe COVID-19 patients

The move comes just days after Gilead allocated nearly all of its supply of remdesivir for the next three months to the US

05 Jul 2020 1:54 PM

Cipla Ltd will price its generic version of Gilead Sciences Inc’s antiviral drug remdesivir for use in COVID-19 patients. (Photo- Twitter)

Cipla to price remdesivir version for COVID-19 under Rs 5,000

Gilead said on Monday it is targeting remdesivir supply for more than 2 million COVID-19 patients by the end of the year.

24 Jun 2020 9:16 AM

1 of 2

Columns

Mohan Guruswamy